Artesunate FDA Approval History
Last updated by Judith Stewart, BPharm on Dec 27, 2020.
FDA Approved: Yes (First approved May 26, 2020)
Generic name: artesunate
Dosage form: for Injection
Company: Amivas (US), LLC
Treatment for: Malaria
Artesunate for Injection is an antimalarial indicated for the initial treatment of severe malaria in adult and pediatric patients.
Development timeline for artesunate
|May 27, 2020||Approval FDA Approves Artesunate for Injection for the Treatment of Severe Malaria|
|Jul 23, 2019||La Jolla Pharmaceutical Company Receives Orphan Designation from FDA for LJPC-0118 (Artesunate) for the Treatment of Malaria|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.